Kidney tissue distribution describes pharmaceutical accumulation in renal compartments potentially causing nephrotoxicity. Glomerular filtration concentrates drugs in ultrafiltrate. Proximal tubular reabsorption concentrates lipophilic drugs. Organic anion transporters actively accumulate anionic drugs. Acute tubular necrosis results from excessive concentration.
Nephroprotective strategies including hydration reduce concentration. Therapeutic drug monitoring guides dose adjustments. Biomarkers including kidney injury molecules detect early toxicity. Regulatory submissions address nephrotoxicity risk. Post-approval surveillance identifies unexpected renal effects.
General Biopharmaceutical Concepts
Kidney Tissue Distribution
Kidney tissue distribution evaluates the extent and pattern of therapeutic compound localisation within renal tissues following administration.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →